heartlinx Medical News about anthracycline cardiotoxicity

Cardiology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Cardiology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Cardiology

Arrhythmias/EP

Atherosclerosis/Lipids

Basic Science/Genetics

Cardiac Surgery

Clinical Pharmacology

Complementary Medicine

Congenital

Coronary Artery Disease

Diagnostics

Economics of Medicine

Epidemiology

Heart Failure

Hypertension

Interventional

Myocardium/Pericardium

Pediatric Cardiology

Physiology

Popular Press

Preventive

Primary Care

Transplant/Augmentation

Valvular Disease

Vascular Medicine

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity
Pediatric Blood & Cancer, 06/09/08

Email This Article

Save in My Library

Free Abstract

Germanakis I et al. - The usefulness of cardiac troponins and natriuretic peptides, the most commonly used biomarkers of myocardial destruction and ventricular dysfunction respectively, to detect and to predict the development of anthracycline cardiotoxicity has been reviewed.

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor